Is it the time to integrate novel sequencing technologies into clinical practice?

Area of Science:

• Genomics
• Molecular Biology
• Clinical Diagnostics

Background:

• Next-generation sequencing (NGS) technologies are rapidly advancing, focusing on improved mutation capture, read accuracy, and cellular resolution.
• Integration of short and long read DNA sequencing with multiomic approaches offers deeper biological insights into diseases.

Approach:

• Utilizing single-cell (sc)DNA-seq and integrated scDNA-seq with immunophenotyping to analyze disease composition at a granular level.
• Employing advanced sequencing to identify rare cell populations for sensitive residual disease monitoring and precise clone characterization.

Key Points:

• scDNA-seq provides detailed information on clonal hierarchy, co-mutation status, zygosity, and genotype-phenotype correlations.
• Techniques enable the distinction of malignant from pre/nonmalignant clones and enhance sensitivity in minimal residual disease monitoring.
• Decreasing costs and increasing genetic insights are making high-throughput NGS a clinical reality.

Conclusions:

• Novel NGS techniques are poised to revolutionize clinical practice by improving diagnostics and treatment response monitoring.
• These technologies will advance the study of premalignant conditions like clonal hematopoiesis.
• The integration of advanced sequencing methods promises more precise disease characterization and patient management.